Middle East & Africa Blood Testing Market Size & Outlook
- Clinical Diagnostics
- In Vitro Diagnostics
- Blood Testing Market Outlook
- In Vitro Diagnostics
Global Market
Related Markets
Ask a question about the blood testing market
MEA blood testing market highlights
- The MEA blood testing market generated a revenue of USD 5,638.6 million in 2024.
- The market is expected to grow at a CAGR of 9.8% from 2025 to 2030.
- In terms of segment, covid-19 testing was the largest revenue generating test type in 2024.
- Glucose testing is the most lucrative test type segment registering the fastest growth during the forecast period.
- Country-wise, Saudi Arabia is expected to register the highest CAGR from 2025 to 2030.
MEA data book summary
| Market revenue in 2024 | USD 5,638.6 million |
| Market revenue in 2030 | USD 9,741.8 million |
| Growth rate | 9.8% (CAGR from 2025 to 2030) |
| Largest segment | Covid-19 testing |
| Fastest growing segment | Glucose testing |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Glucose testing, A1C testing, Direct LDL testing, Lipid panel testing, Prostate-specific antigen testing, COVID-19 testing, BUN testing, Vitamin D testing, Thyroid-stimulating hormone testing, Serum Nicotine / Cotinine testing, High sensitivity CRP testing, Testosterone testing, ALT testing, Cortisol testing, Creatinine testing, AST testing, Other blood tests |
| Key market players worldwide | Abbott Laboratories, Roche Holding AG ADR, Bio-Rad Laboratories Inc, BioMerieux SA, Quest Diagnostics Inc, Biomerica Inc, Becton Dickinson & Co, Siemens Healthineers AG ADR, Danaher Corp, Trinity Biotech PLC ADR |
Other key industry trends
- In terms of revenue, MEA region accounted for 5.8% of the global blood testing market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 36,926.3 million by 2030.
Rising prevalence of non-communicable diseases in the region, increasing initiatives being undertaken by the government to reduce incidence of these diseases, and rising awareness are factors anticipated to fuel the market growth.
Growing awareness about available healthcare, various initiatives being undertaken by various organizations, increasing penetration of health insurance, and privatization of healthcare are some of the factors anticipated to fuel the market growth in this region.
Lack of a well-defined regulatory framework and scarcity of skilled healthcare professionals for diagnosis & treatment are anticipated to hinder the MEA market growth. However, increase in government initiatives to improve healthcare infrastructure in South Africa, Saudi Arabia, and the UAE is creating new opportunities for blood testing market.
No credit card required*
Publish Date: Nov 07, 2025
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Blood Testing Market Scope
Blood Testing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Roche Holding AG ADR | View profile | 103,605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | www.roche.com |
| Abbott Laboratories | View profile | 114,000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | www.abbottinvestor.com |
| Becton Dickinson & Co | View profile | 73,000 | 1 Becton Drive, Franklin Lakes, NJ, United States, 07417-1880 | www.bd.com |
| BioMerieux SA | View profile | 13,982 | Marcy l’Etoile, Lyon, France, 69280 | www.biomerieux.com |
| Siemens Healthineers AG ADR | View profile | 71,400 | Siemensstr. 3, Forchheim, BY, Germany, 91301 | www.siemens-healthineers.com |
| Danaher Corp | View profile | 63,000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | www.danaher.com |
| Quest Diagnostics Inc | View profile | 48,000 | 500 Plaza Drive, Secaucus, NJ, United States, 07094 | www.questdiagnostics.com |
| Bio-Rad Laboratories Inc | View profile | 8,030 | 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 | www.bio-rad.com |
| Biomerica Inc | View profile | 62 | 17571 Von Karman Avenue, Irvine, CA, United States, 92614 | www.biomerica.com |
| Trinity Biotech PLC ADR | View profile | 380 | IDA Business Park, Bray, County Wicklow, Dublin, Ireland, A98 H5C8 | www.trinitybiotech.com |
Middle East & Africa Blood Testing Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Blood Testing Market Outlook will help companies and investors design strategic landscapes.
Covid-19 Testing was the largest segment with a revenue share of 20.09% in 2024.
Horizon Databook has segmented the Middle East & Africa blood testing market based on glucose testing, a1c testing, direct ldl testing, lipid panel testing, prostate-specific antigen testing, covid-19 testing, bun testing, vitamin d testing, thyroid-stimulating hormone testing, serum nicotine / cotinine testing, high sensitivity crp testing, testosterone testing, alt testing, cortisol testing, creatinine testing, ast testing, other blood tests covering the revenue growth of each sub-segment from 2018 to 2030.
Rising prevalence of non-communicable diseases in the region, increasing initiatives being undertaken by the government to reduce incidence of these diseases, and rising awareness are factors anticipated to fuel the market growth.
Growing awareness about available healthcare, various initiatives being undertaken by various organizations, increasing penetration of health insurance, and privatization of healthcare are some of the factors anticipated to fuel the market growth in this region.
Lack of a well-defined regulatory framework and scarcity of skilled healthcare professionals for diagnosis & treatment are anticipated to hinder the MEA market growth. However, increase in government initiatives to improve healthcare infrastructure in South Africa, Saudi Arabia, and the UAE is creating new opportunities for blood testing market.
- Middle East & Africa Blood Testing Market Test Type Outlook (Revenue, USD Million , 2018-2030)
- Glucose testing
- A1C testing
- Direct LDL testing
- Lipid panel testing
- Prostate-specific antigen testing
- COVID-19 testing
- BUN testing
- Vitamin D testing
- Thyroid-stimulating hormone testing
- Serum Nicotine / Cotinine testing
- High sensitivity CRP testing
- Testosterone testing
- ALT testing
- Cortisol testing
- Creatinine testing
- AST testing
- Other blood tests
Reasons to subscribe to Blood Testing Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Blood Testing Market Outlook databook
- Our clientele includes a mix of Blood Testing Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa Blood Testing Market Outlook, including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa Blood Testing Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Middle East Africa Blood Testing Market, 2018-2030 (US$M)
MEA blood testing market statistics, by test type, 2018-2030 (US$M)
